SAHPRA Approves The Use Of Sinovac Vaccine

The South African Health Products Regulatory Authority has approved the use of the Sinovac Covid-19 vaccine.

However, under certain conditions.

The approval is under Section 21 of the Medicines and Related Substance Act.

Individuals between the ages of 18 and 59 years can use the vaccine.

There are two doses that are administered 14 to 28 days apart.

One of the conditions is that Sinovac must submit the final results of ongoing clinical studies.

It also needs to submit periodic safety updates.

The Sinovac vaccine has a provisional shelf life of 24 months.